Cargando…
Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs
Clinical development of new anticancer drugs can be compromised by a lack of qualified biomarkers. An indispensable component to successful biomarker qualification is assay validation, which is also a regulatory requirement. In order to foster flexible yet rigorous biomarker method validation, the f...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990602/ https://www.ncbi.nlm.nih.gov/pubmed/20924371 http://dx.doi.org/10.1038/sj.bjc.6605910 |